SEARCH

UPCOMING LIVE SEMINARS
 






Writing Clinical Study Protocols May 2011

Course Description 

The basis and success of any drug or device development program is the clinical trial protocol. Clinical trials conducted under an IND or IDE cannot begin without a protocol, and yet there is variability between companies and individuals on how to approach writing this critical document. Clinical trials and entire programs have failed because the protocol was not scientifically sound. Knowing how to effectively research and write a clinical trial protocol is essential to a compound achieving IRB and ultimately market approval.

Over the course of any development plan, new protocols, protocol amendments, and protocol concept sheets will be needed on an ongoing basis. Though they require similar information, protocols for Phases 1, 2, 3 and 4 require different writing approaches. As a writer of a protocol, you need to know what the agency expects to see at every development milestone to avoid the trial being put on clinical hold. Moreover, amendments, however unwelcome, are a necessary part of the development process. Amendments need to be managed efficiently to avoid costly implementation or delays to the ongoing trial.

VideoPreview

 

Learning Objectives 

  • Describe the overall structure of a protocol and regulatory requirements
  • Describe the requirements for a protocol, including:
          o Establishing the indication(s)
          o Types of studies (prospective, observational, retrospective)
          o Design (single blind, double blind, randomized, etc.)
          o Establishing the hypothesis
          o What is safety and efficacy and how do you establish either or both
          o Determining inclusion/exclusion criteria
          o Determining the Schedule of Events
          o Adverse and serious adverse event reporting

Who Should Attend 

  • Medical Directors
  • Medical Writers
  • Clinical Research Associates
  • Regulatory Affairs
  • Research and Development

Instructor 

Meredith Brown-Tuttle, R.A.C.

Click here for complete trainer biographies 

Course Length Time 

3 hours; 12:00 - 3:00 p.m. Eastern

Course Dates 

May 4, 2011

Hold this course at your company!
For more information, contact Naila Ganatra at (215) 413-2471

FOLLOW US ON: 

LinkedIn twitter Facebook 


On-Demand GCP Refresher Training 

Too busy to attend a course? Our newly-released GCP eLearning course may be your solution!
For details on our scenario-based practical GCP application on-demand course, click here.


GCP for Investigators
 

Barnett’s scenario-based eLearning course is designed with the busy Principal Investigator in mind.  Based on real-life scenarios encountered by investigative site teams, this highly focused 7-module GCP training is designed to ensure comprehensive understanding of the key components of GCP.

For more details on this scenario-based eGCP program for investigators please click here. 


BARNETT CATALOG The Barnett Catalogue is your comprehensive guide to the myriad live, web, and custom training opportunities offered throughout the year. 

Jan - July 2014 Edition

Winter CatalogDownload Today!  

Blended Curriculum Path for the CRA, CRC, and Project Manager

BCP Cover

Download Today! 

 

 

 


 

DVD IconWEB SEMINAR ARCHIVE 

 View Catalog of Offerings   

New Titles added every month! 
Course Alumni Save 50% 


Live SeminarLIVE SEMINARS

Monitoring Clinical Drug Studies: Intermediate 

Informed Consent Content & Process Requirements for Biobanking Studies 

Auditing Techniques for Clinical Research Professionals 


Web SeminarWEB SEMINARS

10-Week CRA & CRC Beginner Program  

Trial Master File (TMF) for Sponsors: Set-Up and Maintenance 

Use of Notes to File in Clinical Trial Essential Documentation 

10-Week Clinical Research Associate (CRA) On-Boarding Program  


PublicationsPUBLICATIONS

2012 GCP Question & Answer Guide Print Edition 

2012 Good Clinical Practice Question & Answer Guide Electronic Edition 

CFR/ICH GCP Reference Guide 2012 (Spiral Bound) 

CFR/ICH GCP Reference Guide 2012 (Perfect Bound) 

PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2012/2013 (Hard Copy)